Published in Pharma Law Weekly, October 25th, 2005
The results were published in the September 15, 2005, issue of Clinical Cancer Research (Vol. 11, Issue 18, pp. 6625-6633). Christopher J. Sweeney, MD, codirector, experimental and developmental therapeutics program, Indiana University Cancer Center and George Wilding, MD, Director, University of Wisconsin Comprehensive Cancer Center were Principal Investigators for the phase II study.
In this double-blind, randomized phase II study, 33 patients received either 400...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.